Delic Corp Inc. (CSE: DELC) (OTCQB: DELCF), the leading psychedelic wellness platform, has announced one of its headline speakers for its upcoming Meet Delic event. Award-winning investigative reporter Ben Westhoff will present a keynote address titled “Fentanyl in Our Drugs,” which will discuss how fentanyl is upending the entire recreational drug landscape. His presentation includes a look at how fentanyl impacts drug-legalization prospects, dark-web markets, geopolitics and much more. Westhoff focuses his reporting on culture, drugs and poverty, and his book, titled “Fentanyl, Inc.: How Rogue Chemists Created the Deadliest Wave of the Opioid Epidemic” has been called a bombshell book about the fentanyl epidemic. He has written for “The Atlantic,” “The Wall Street Journal,” “Rolling Stone” and “The Guardian.” Delic Corp. presents Meet Delic, which is a two-day immersive edutainment experience for the world’s leading psychedelic and wellness thought and business leaders. The two-day event is scheduled for Nov. 6–7, 2021, in Las Vegas.“Ben’s thought-provoking journalism has exposed serious problems with the way we fight drug abuse and opens up the possibility of better treatment with far fewer side effects,” said Delic co-founder Jackee Stang in the press release. “His objective take on the realm of treatments will be incredibly interesting and educational for the Meet Delic audience.”
To register for the event, visit https://nnw.fm/p2Xrp
To view the full press release, visit https://nnw.fm/yxWNI
About Delic Corp Inc.
Delic is the leading psychedelic wellness platform, committed to bringing science-backed benefits to all and reframing the psychedelic conversation. The company owns and operates an umbrella of related businesses, including trusted media and e-commerce platforms such as Reality Sandwich; Delic Radio; Delic Labs, the only licensed entity by Health Canada to exclusively focus on research and development of psilocybin vaporization technology; Meet Delic, the premiere psychedelic wellness event; and Ketamine Infusion Centers, one of the largest ketamine clinics in the country. Delic is backed by a team of industry and cannabis veterans and a diverse network whose mission is to provide education, research, high-quality products and treatment options to the masses. For more information about the company, visit www.DelicCorp.com.
NOTE TO INVESTORS: The latest news and updates relating to DELCF are available in the company’s newsroom at https://nnw.fm/DELCF
About NetworkNewsWire
NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 888-902-4192 (U.S. Mobile Phones Only)
For more information please visit https://www.networknewswire.com
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
NetworkNewsWire (NNW)
New York, New York
www.networknewswire.com
212.418.1217 Office
[email protected]
NetworkNewsWire is part of the InvestorBrandNetwork
